Varex/$VREX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Varex
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.
Ticker
$VREX
Sector
Primary listing
Employees
2,300
Headquarters
Website
Varex Metrics
BasicAdvanced
$477M
-
-$3.22
0.68
-
Price and volume
Market cap
$477M
Beta
0.68
52-week high
$16.47
52-week low
$6.76
Average daily volume
487K
Financial strength
Current ratio
3.506
Quick ratio
1.639
Long term debt to equity
83.301
Total debt to equity
84.537
Interest coverage (TTM)
-1.04%
Profitability
EBITDA (TTM)
-9.4
Gross margin (TTM)
34.06%
Net profit margin (TTM)
-16.13%
Operating margin (TTM)
-4.44%
Effective tax rate (TTM)
-86.44%
Revenue per employee (TTM)
$360,000
Management effectiveness
Return on assets (TTM)
-1.96%
Return on equity (TTM)
-24.79%
Valuation
Price to revenue (TTM)
0.577
Price to book
1.05
Price to tangible book (TTM)
1.97
Price to free cash flow (TTM)
13.01
Free cash flow yield (TTM)
7.69%
Free cash flow per share (TTM)
0.882
Growth
Revenue change (TTM)
-1.36%
Earnings per share change (TTM)
-502.13%
3-year revenue growth (CAGR)
-1.30%
3-year earnings per share growth (CAGR)
73.80%
What the Analysts think about Varex
Analyst ratings (Buy, Hold, Sell) for Varex stock.
Bulls say / Bears say
In Q2 FY25, Varex posted 3% revenue growth to $213 million and expanded non-GAAP gross margin by 350 basis points to 36%, fueling a 63% jump in non-GAAP EPS to $0.26—a sign of greater operational efficiency.
Varex’s Industrial segment continues building momentum, winning a $25 million export order from a global customer for high-energy cargo inspection systems. This highlights robust demand and adds to its sales backlog.
The company ended Q2 FY25 with $226 million in liquidity and has set aside $125 million as restricted cash to help repay its $200 million convertible notes maturing in June 2025, a move that will significantly reduce its leverage and strengthen the balance sheet.
China’s Ministry of Commerce has launched an anti-dumping probe on U.S. and Indian imports of medical CT X-ray tubes, raising the risk of trade restrictions that could disrupt Varex’s largest market and triggering a 16.3% drop in the stock.
For Q3 FY25, Varex expects revenue of $180 million to $200 million and non-GAAP EPS between -$0.05 and $0.10, both below analysts’ estimates of $209 million and $0.17, respectively, indicating softer customer demand near-term.
China has imposed a 74.9% anti-dumping duty on polyformaldehyde copolymers, key materials for X-ray components, which could increase Varex’s raw material costs by up to 200 basis points, tightening margins and complicating the company’s supply chain.
Data summarised monthly by Lightyear AI. Last updated on 4 Sept 2025.
Varex Financial Performance
Revenues and expenses
Varex Earnings Performance
Company profitability
Varex News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Varex stock?
Varex (VREX) has a market cap of $477M as of September 16, 2025.
What is the P/E ratio for Varex stock?
The price to earnings (P/E) ratio for Varex (VREX) stock is 0 as of September 16, 2025.
Does Varex stock pay dividends?
No, Varex (VREX) stock does not pay dividends to its shareholders as of September 16, 2025.
When is the next Varex dividend payment date?
Varex (VREX) stock does not pay dividends to its shareholders.
What is the beta indicator for Varex?
Varex (VREX) has a beta rating of 0.68. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.